Screening data from 19 patients with late‐onset Pompe disease for a phase I clinical trial of AAV8 vector‐mediated gene therapy
Abstract Late‐onset Pompe disease (LOPD) is a multisystem disorder with significant myopathy. The standard treatment is enzyme replacement therapy (ERT), a therapy that is lifesaving, yet with limitations. Clinical trials have emerged for other potential treatment options, including adeno‐associated...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
Wiley
2023-09-01
|
| 丛编: | JIMD Reports |
| 主题: | |
| 在线阅读: | https://doi.org/10.1002/jmd2.12391 |
| 标签: |
没有标签, 成为第一个标记此记录!
|
